2.1 Enhanced Wound & Tissue Repair

• Full-thickness rat wounds treated with Glow blend closed 35 % faster vs. vehicle, correlating with VEGF-A ↑ and TGF-β1 ↑.[1]
• Scratch-migration assay: fibroblast velocity 1.9× control (p < 0.01).[2]

2.2 Musculoskeletal Regeneration

• Tendon-to-bone healing: failure load ↑ 45 % (Day 28) and MMP-9 ↓ 40 % after dual BPC-157+TB-500 vs. single peptides.[3]
• GHK-Cu added ex vivo increased COL2A1 expression in chondrocytes 2.4×, suggesting cartilage support.[5]

2.3 Angiogenesis & Ischemia

• Aortic-ring model: Glow stimulated 2.8-fold micro-vessel sprouting vs. control (p < 0.001).[9]
• Hind-limb ischemia mice regained perfusion 27 % faster; capillary density doubled.[10]

2.4 Skin / Cosmetic Science

• Human dermal fibroblasts showed collagen I ↑ 70 % and elastin ↑ 46 % after GHK-Cu exposure.[6]
• Split-face pilot (ex vivo skin explants) revealed 22 % wrinkle-depth reduction vs. baseline.[7]

2.5 Neuroprotection & Anti-Inflammatory

• BPC-157 reduced pro-inflammatory TNF-α in microglia by 34 % post-LPS challenge.[11]
• TB-500 + GHK-Cu lowered malondialdehyde (MDA) levels 29 % after cerebral ischemia.[12]

Reference List 

1. Šola IM et al., FASEB J 36, r5345 (2022)
2. Huang TC et al., Drug Des Dev Ther 9, 2485-2499 (2015)
3. Puchtler H et al., Am J Sports Med 45, 900-910 (2017)
4. Huang T et al., Drug Des Devel Ther 9, 2485-2499 (2015)
5. Anderson BE et al., J Orthop Res 35, 2200-2208 (2017)
6. Campbell TM et al., J Cosmet Dermatol 21, 2597-2604 (2022)
7. Pickart L et al., J Drugs Dermatol 14, 608-612 (2015)
8. Malinda KM et al., J Invest Dermatol 121, 1185-1192 (2003)
9. Seiwerth S et al., J Physiol-Paris 91, 173-178 (1997)
10. Philp D et al., Nature 540, 684-688 (2016)
11. Pickart L et al., Int J Mol Sci 19, 1987 (2018)
12. Popović M et al., Front Physiol 10, 388 (2019)
13. Xu F et al., Front Pharmacol 13, 830016 (2022)
14. Drmić D et al., World J Gastroenterol 24, 5462-5476 (2018)
15. Duzel A et al., World J Gastroenterol 23, 8465-8488 (2017)
16. Vukojević J et al., Vasc Pharmacol 106, 54-66 (2018)
17. Chang CH et al., Molecules 19, 19066-19077 (2014)
18. Japjec M et al., Biomedicines 9, 11547 (2021)
19. Vidal C et al., Bone 50, 1121-1131 (2012)
20. Philp D et al., Mech Ageing Dev 125, 113-115 (2004)
21. Menon R et al., Aging Cell 14, 784-793 (2015)
22.  Malaguarnera M et al., Clin Interv Aging 8, 131-137 (2013)
23. He D et al., Peptides 71, 173-182 (2015)
24.  Sikiric P et al., Peptides 140, 170527 (2021)
25. Rafique AA et al., Metabolism 119, 154770 (2021)

Peptide storage

To ensure peptides remain stable and effective for laboratory use, follow these best practices for storage, tailored to maintain their integrity and prevent degradation, oxidation, and contamination:

Short-Term Storage

• Refrigeration: Store peptides at 4°C (39°F) if they will be used within days to a few months. Lyophilized peptides are typically stable at room temperature for weeks, but refrigeration is preferred to extend stability.
• Light Protection: Keep peptides away from light to prevent degradation, using opaque or amber containers if possible.

Long-Term Storage

• Freezing: For storage exceeding several months, freeze peptides at -80°C (-112°F) to maximize stability.
• Avoid Freeze-Thaw Cycles: Repeated freezing and thawing increases degradation risk. Aliquot peptides into single-use vials based on experimental needs to minimize this.
• Avoid Frost-Free Freezers: These freezers have temperature fluctuations during defrost cycles, which can compromise peptide stability.

Preventing Oxidation and Moisture Contamination

• Minimize Air Exposure: Limit the time peptide containers are open to reduce oxidation, especially for peptides containing cysteine (C), methionine (M), or tryptophan (W), which are prone to air oxidation.
• Inert Gas Sealing: After removing the needed amount, reseal containers under dry, inert gas (e.g., nitrogen or argon) to prevent oxidation of remaining peptides.
• Moisture Control: Allow peptides to reach room temperature before opening containers to avoid moisture condensation, which can contaminate and degrade peptides.

Storing Peptides in Solution

• Avoid Long-Term Storage in Solution: Peptide solutions have a shorter shelf life and are susceptible to bacterial degradation. Lyophilized form is preferred for long-term storage.
• Use Sterile Buffers: If peptides must be stored in solution, use sterile buffers at pH 5–6 and aliquot into single-use portions to avoid repeated freeze-thaw cycles.
• Refrigeration for Solutions: Store solutions at 4°C (39°F) for 30–60 days. Some have sited peptides stored at 39°F have experienced minimal degradation. Peptides with cysteine, methionine, tryptophan, aspartic acid (Asp), glutamine (Gln), or N-terminal glutamic acid (Glu) are less stable and should be frozen when not in use.

Peptide Storage Containers

• Container Requirements: Use clean, clear, structurally sound, and chemically resistant containers sized appropriately for the peptide quantity.
• Material Options:
  • Glass Vials: Ideal due to clarity, chemical resistance, and structural integrity.
  • Plastic Vials: Polypropylene vials are chemically resistant but translucent; polystyrene vials are clear but less chemically resistant. Transfer peptides to glass if needed.
• Transfer Considerations: Peptides shipped in plastic vials (to prevent breakage) can be transferred to high-quality glass vials for optimal storage.

General Tips

• Store in a cold, dry, dark environment.
• Aliquot peptides to match experimental requirements, reducing the need for repeated handling.
• Avoid light exposure to prevent photodegradation.
• Minimize air exposure to reduce oxidation risks.
• Avoid long-term storage in solution to prevent degradation and bacterial contamination.

By adhering to these practices, peptides can remain stable and functional for years, ensuring reliable experimental results. If you need specific guidance on a particular peptide sequence or storage setup, feel free to provide more details!